News
TEVA
36.90
-1.91%
-0.72
BioXcel Files for Bankruptcy With Deal to Sell Assets to Teva
Dow Jones · 5h ago
Teva unit bids to acquire neuroscience product from BioXcel Therapeutics
TipRanks · 5h ago
BioXcel files for Chapter 11, will sell assets to Teva
Seeking Alpha · 5h ago
*Teva Pharmaceuticals: Deal Part of Court-Supervised Sale Process With BioXcel Therapeutics
Dow Jones · 5h ago
BioXcel Therapeutics enters asset sale agreement with Teva
TipRanks · 5h ago
Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
Barchart · 10h ago
Piper Sandler Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)
TipRanks · 1d ago
Teva Pharmaceutical Rocked by Eye-Catching Insider Stock Moves
TipRanks · 2d ago
Teva business practices under scrutiny in Turkish antitrust probe
Seeking Alpha · 2d ago
Teva Pharmaceutical Industries (TEVA) Could Be 10% Undervalued After FDA Accepted Ecopipam NDA
Simply Wall St · 3d ago
Weekly Report: what happened at TEVA last week (0817-0821)?
Weekly Report · 4d ago
Ecopipam Priority Review Could Be A Game Changer For Teva Pharmaceutical Industries (TEVA)
Simply Wall St · 5d ago
Alvotech: Reiterate Hold On AVT05/AVT06 BLA Resubmissions And Upcoming Catalysts
Seeking Alpha · 08/20 18:21
Is NBIX Stock a Buy as Fast Growth Meets a Premium Sales Valuation?
NASDAQ · 08/20 15:14
Teva (TEVA) Wins FDA Priority Review For Pediatric Tourette Drug Candidate
Simply Wall St · 08/20 13:30
Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug
Benzinga · 08/20 13:30
Aurinia Settles Patent Infringement Lawsuit With Teva
Dow Jones · 08/19 20:44
*Aurinia: Related Patent Infringement Actions Continue Against DifGen Pharmaceuticals, Dr. Reddy's, Others
Dow Jones · 08/19 20:09
*Aurinia: Teva May Launch Its Generic Voclosporin Pdt No Earlier Than Dec 7, 2036, Unless Certain Defined Contingencies Occur Earlier >AUPH
Dow Jones · 08/19 20:08
*Aurinia: Teva Stipulated That Aurinia's Patents Are Enforceable, Valid, and Would Be Infringed
Dow Jones · 08/19 20:08
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.